Skip to main content
Erschienen in: Diabetologia 9/2006

01.09.2006 | Article

Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice

verfasst von: M. Jeansson, A. Björnson Granqvist, J. Sörensson Nyström, B. Haraldsson

Erschienen in: Diabetologia | Ausgabe 9/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Despite the fact that diabetic nephropathy is an increasingly common disorder that may lead to uraemia, the underlying mechanisms are still poorly understood and there is no specific therapy. To clarify whether long-term diabetes alters glomerular size- or charge-selectivity or both, we studied non-obese diabetic mice for up to 40 weeks.

Materials and methods

During the study period, spot urine was collected and blood pressure measured. At weeks 10 and 40, the right kidney was isolated and perfused at 8°C to inhibit tubular function, allowing for analysis of glomerular selectivity with albumin and Ficoll clearance. The left kidney was removed for further investigation using electron microscopy and molecular biology. Real-time PCR with low-density arrays was done to evaluate renal cortex mRNA expression of proteoglycans and other components in the glomerular barrier. After 40 weeks of diabetes, kidneys showed morphological changes typical of diabetic complications.

Results

At 40 weeks, the fractional clearance for negatively charged albumin was three times higher in the diabetic animals (0.0160) than in controls (0.0051, p<0.001), while fractional clearance for neutral Ficoll 35.5 Å with a Stokes Einstein radius similar to that of albumin was unaffected. In addition, protein and mRNA levels for versican and decorin were downregulated after 40 weeks of diabetes.

Conclusions/interpretation

We conclude that glomerular charge- but not size-selectivity was impaired in the diabetic animals with proteinuria. Also, glomerular components such as versican, decorin and fibromodulin were found to be downregulated after 40 weeks of diabetes.
Literatur
1.
Zurück zum Zitat Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS (2001) CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159:2303–2308PubMed Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS (2001) CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol 159:2303–2308PubMed
2.
Zurück zum Zitat Ruotsalainen V, Ljungberg P, Wartiovaara J et al (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci 96:7962–7967PubMedCrossRef Ruotsalainen V, Ljungberg P, Wartiovaara J et al (1999) Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci 96:7962–7967PubMedCrossRef
3.
Zurück zum Zitat Roselli S, Gribouval O, Boute N et al (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:131–139PubMed Roselli S, Gribouval O, Boute N et al (2002) Podocin localizes in the kidney to the slit diaphragm area. Am J Pathol 160:131–139PubMed
4.
Zurück zum Zitat Sörensson J, Ohlson M, Lindström K, Haraldsson B (1998) Glomerular charge selectivity for horseradish peroxidase and albumin at low and normal ionic strengths. Acta Physiol Scand 163:83–91PubMedCrossRef Sörensson J, Ohlson M, Lindström K, Haraldsson B (1998) Glomerular charge selectivity for horseradish peroxidase and albumin at low and normal ionic strengths. Acta Physiol Scand 163:83–91PubMedCrossRef
5.
Zurück zum Zitat Haraldsson B, Sorensson J (2004) Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 19:7–10PubMed Haraldsson B, Sorensson J (2004) Why do we not all have proteinuria? An update of our current understanding of the glomerular barrier. News Physiol Sci 19:7–10PubMed
6.
Zurück zum Zitat Hjalmarsson C, Johansson BR, Haraldsson B (2004) Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res 67:9–17PubMedCrossRef Hjalmarsson C, Johansson BR, Haraldsson B (2004) Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvasc Res 67:9–17PubMedCrossRef
7.
Zurück zum Zitat Ciarimboli G, Hjalmarsson C, Bokenkamp A, Schurek HJ, Haraldsson B (2003) Dynamic alterations of glomerular charge density in fixed rat kidneys suggest involvement of endothelial cell coat. Am J Physiol Renal Physiol 285:F722–F730PubMed Ciarimboli G, Hjalmarsson C, Bokenkamp A, Schurek HJ, Haraldsson B (2003) Dynamic alterations of glomerular charge density in fixed rat kidneys suggest involvement of endothelial cell coat. Am J Physiol Renal Physiol 285:F722–F730PubMed
8.
Zurück zum Zitat Ohlson M, Sörensson J, Haraldsson B (2001) A gel-membrane model of glomerular charge and size selectivity in series. Am J Physiol Renal Physiol 280:F396–F405PubMed Ohlson M, Sörensson J, Haraldsson B (2001) A gel-membrane model of glomerular charge and size selectivity in series. Am J Physiol Renal Physiol 280:F396–F405PubMed
9.
Zurück zum Zitat Jeansson M, Haraldsson B (2003) Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14:1756–1765PubMedCrossRef Jeansson M, Haraldsson B (2003) Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. J Am Soc Nephrol 14:1756–1765PubMedCrossRef
10.
Zurück zum Zitat Bjornson A, Moses J, Ingemansson A, Haraldsson B, Sorensson J (2005) Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am J Physiol Renal Physiol 288:F748–F756PubMedCrossRef Bjornson A, Moses J, Ingemansson A, Haraldsson B, Sorensson J (2005) Primary human glomerular endothelial cells produce proteoglycans, and puromycin affects their posttranslational modification. Am J Physiol Renal Physiol 288:F748–F756PubMedCrossRef
11.
Zurück zum Zitat Avasthi PS, Koshy V (1988) Pathophysiology and clinical relevance of proteinuria: glomerular endothelial glycocalyx. Contrib Nephrol 68:104–113PubMed Avasthi PS, Koshy V (1988) Pathophysiology and clinical relevance of proteinuria: glomerular endothelial glycocalyx. Contrib Nephrol 68:104–113PubMed
12.
Zurück zum Zitat Deen WM (2004) What determines glomerular capillary permeability? J Clin Invest 114:1412–1414PubMed Deen WM (2004) What determines glomerular capillary permeability? J Clin Invest 114:1412–1414PubMed
13.
Zurück zum Zitat Deckert T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andreasen HB, Feldt-Rasmussen B (1993) Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36:244–251PubMedCrossRef Deckert T, Kofoed-Enevoldsen A, Vidal P, Norgaard K, Andreasen HB, Feldt-Rasmussen B (1993) Size- and charge selectivity of glomerular filtration in type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 36:244–251PubMedCrossRef
14.
Zurück zum Zitat Friedman S, Jones HW 3rd, Golbetz HV, Lee JA, Little HL, Myers BD (1983) Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier. Diabetes 32(Suppl 2):40–46PubMed Friedman S, Jones HW 3rd, Golbetz HV, Lee JA, Little HL, Myers BD (1983) Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier. Diabetes 32(Suppl 2):40–46PubMed
15.
Zurück zum Zitat Nakamura Y, Myers BD (1988) Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37:1202–1211PubMedCrossRef Nakamura Y, Myers BD (1988) Charge selectivity of proteinuria in diabetic glomerulopathy. Diabetes 37:1202–1211PubMedCrossRef
16.
Zurück zum Zitat Tomlanovich S, Deen WM, Jones HW 3rd, Schwartz HC, Myers BD (1987) Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes 36:556–565PubMedCrossRef Tomlanovich S, Deen WM, Jones HW 3rd, Schwartz HC, Myers BD (1987) Functional nature of glomerular injury in progressive diabetic glomerulopathy. Diabetes 36:556–565PubMedCrossRef
17.
Zurück zum Zitat Bangstad HJ, Kofoed-Enevoldsen A, Dahl-Jorgensen K, Hanssen KF (1992) Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35:1165–1169PubMedCrossRef Bangstad HJ, Kofoed-Enevoldsen A, Dahl-Jorgensen K, Hanssen KF (1992) Glomerular charge selectivity and the influence of improved blood glucose control in type 1 (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35:1165–1169PubMedCrossRef
18.
Zurück zum Zitat Pietravalle P, Morano S, Cristina G et al (1991) Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 40:1685–1690PubMedCrossRef Pietravalle P, Morano S, Cristina G et al (1991) Charge selectivity of proteinuria in type I diabetes explored by Ig subclass clearance. Diabetes 40:1685–1690PubMedCrossRef
19.
Zurück zum Zitat Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100–106PubMedCrossRef Deckert T, Feldt-Rasmussen B, Djurup R, Deckert M (1988) Glomerular size and charge selectivity in insulin-dependent diabetes mellitus. Kidney Int 33:100–106PubMedCrossRef
20.
Zurück zum Zitat Scandling JD, Myers BD (1992) Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 41:840–846PubMedCrossRef Scandling JD, Myers BD (1992) Glomerular size-selectivity and microalbuminuria in early diabetic glomerular disease. Kidney Int 41:840–846PubMedCrossRef
21.
Zurück zum Zitat Lemley KV, Blouch K, Abdullah I et al (2000) Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 11:2095–2105PubMed Lemley KV, Blouch K, Abdullah I et al (2000) Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 11:2095–2105PubMed
22.
Zurück zum Zitat Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD (2000) Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int 58:2129–2137PubMedCrossRef Andersen S, Blouch K, Bialek J, Deckert M, Parving HH, Myers BD (2000) Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int 58:2129–2137PubMedCrossRef
23.
Zurück zum Zitat Torffvit O, Rippe B (1999) Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus: urinary immunoglobulins and glycosaminoglycans. Nephron 83:301–307PubMedCrossRef Torffvit O, Rippe B (1999) Size and charge selectivity of the glomerular filter in patients with insulin-dependent diabetes mellitus: urinary immunoglobulins and glycosaminoglycans. Nephron 83:301–307PubMedCrossRef
24.
Zurück zum Zitat Osicka TM, Pratt LM, Comper WD (1996) Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 2:199–212CrossRef Osicka TM, Pratt LM, Comper WD (1996) Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrology 2:199–212CrossRef
25.
Zurück zum Zitat Ohlson M, Sörensson J, Haraldsson B (2000) Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin. Am J Physiol Renal Physiol 279:F84–F91PubMed Ohlson M, Sörensson J, Haraldsson B (2000) Glomerular size and charge selectivity in the rat as revealed by FITC-Ficoll and albumin. Am J Physiol Renal Physiol 279:F84–F91PubMed
26.
Zurück zum Zitat Johnsson E, Haraldsson B (1992) An isolated perfused rat kidney preparation designed for assessment of glomerular permeability characteristics. Acta Physiol Scand 144:65–73PubMedCrossRef Johnsson E, Haraldsson B (1992) An isolated perfused rat kidney preparation designed for assessment of glomerular permeability characteristics. Acta Physiol Scand 144:65–73PubMedCrossRef
27.
Zurück zum Zitat Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM (1992) Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41:1070–1080PubMedCrossRef Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM (1992) Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 41:1070–1080PubMedCrossRef
28.
Zurück zum Zitat Tamsma JT, van den Born J, Bruijn JA et al (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320PubMedCrossRef Tamsma JT, van den Born J, Bruijn JA et al (1994) Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 37:313–320PubMedCrossRef
29.
Zurück zum Zitat Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N (1991) Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45:119–131PubMedCrossRef Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N (1991) Enalapril improves albuminuria by preventing glomerular loss of heparan sulfate in diabetic rats. Biochem Med Metab Biol 45:119–131PubMedCrossRef
30.
Zurück zum Zitat Wu VY, Wilson B, Cohen MP (1987) Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 36:679–683PubMedCrossRef Wu VY, Wilson B, Cohen MP (1987) Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 36:679–683PubMedCrossRef
31.
Zurück zum Zitat Conde-Knape K (2001) Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev 17:412–421PubMedCrossRef Conde-Knape K (2001) Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev 17:412–421PubMedCrossRef
32.
Zurück zum Zitat Rossi M, Morita H, Sormunen R et al (2003) Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 22:236–245PubMedCrossRef Rossi M, Morita H, Sormunen R et al (2003) Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J 22:236–245PubMedCrossRef
33.
Zurück zum Zitat Rippe B, Haraldsson B (1994) Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 74:163–219PubMed Rippe B, Haraldsson B (1994) Transport of macromolecules across microvascular walls: the two-pore theory. Physiol Rev 74:163–219PubMed
34.
Zurück zum Zitat Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1–13PubMed Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y (1980) Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29:1–13PubMed
35.
Zurück zum Zitat Craighead JE (1980) Experimental models of juvenile onset (insulin-dependent) diabetes mellitus. Monogr Pathol 21:166–176PubMed Craighead JE (1980) Experimental models of juvenile onset (insulin-dependent) diabetes mellitus. Monogr Pathol 21:166–176PubMed
36.
Zurück zum Zitat Maeda M, Yabuki A, Suzuki S, Matsumoto M, Taniguchi K, Nishinakagawa H (2003) Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: acute phase of diabetes. Vet Pathol 40:187–195PubMedCrossRef Maeda M, Yabuki A, Suzuki S, Matsumoto M, Taniguchi K, Nishinakagawa H (2003) Renal lesions in spontaneous insulin-dependent diabetes mellitus in the nonobese diabetic mouse: acute phase of diabetes. Vet Pathol 40:187–195PubMedCrossRef
37.
Zurück zum Zitat Doi T, Hattori M, Agodoa LY et al (1990) Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest 63:204–212PubMed Doi T, Hattori M, Agodoa LY et al (1990) Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest 63:204–212PubMed
38.
Zurück zum Zitat Hryciw DH, Lee EM, Pollock CA, Poronnik P (2004) Molecular changes in proximal tubule function in diabetes mellitus. Clin Exp Pharmacol Physiol 31:372–379PubMedCrossRef Hryciw DH, Lee EM, Pollock CA, Poronnik P (2004) Molecular changes in proximal tubule function in diabetes mellitus. Clin Exp Pharmacol Physiol 31:372–379PubMedCrossRef
39.
Zurück zum Zitat Esmann M, Skou JC (1988) Temperature-dependencies of various catalytic activities of membrane-bound Na+/K+-ATPase from ox brain, ox kidney and shark rectal gland and of C12E8-solubilized shark Na+/K+-ATPase. Biochim Biophys Acta 944:344–350PubMedCrossRef Esmann M, Skou JC (1988) Temperature-dependencies of various catalytic activities of membrane-bound Na+/K+-ATPase from ox brain, ox kidney and shark rectal gland and of C12E8-solubilized shark Na+/K+-ATPase. Biochim Biophys Acta 944:344–350PubMedCrossRef
40.
Zurück zum Zitat Charnoch JS, Doty DM, Russel JC (1971) The effect of temperature on the activity of Na+/K+-ATPase. Arch Biochem Biophys 142:633–637CrossRef Charnoch JS, Doty DM, Russel JC (1971) The effect of temperature on the activity of Na+/K+-ATPase. Arch Biochem Biophys 142:633–637CrossRef
41.
Zurück zum Zitat Sörensson J, Ohlson M, Haraldsson B (2001) A quantitative analysis of the glomerular charge barrier in the rat. Am J Physiol Renal Physiol 280:F646–F656PubMed Sörensson J, Ohlson M, Haraldsson B (2001) A quantitative analysis of the glomerular charge barrier in the rat. Am J Physiol Renal Physiol 280:F646–F656PubMed
42.
Zurück zum Zitat Hjalmarsson C, Ohlson M, Haraldsson B (2001) Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density. Am J Physiol Renal Physiol 281:F503–F512PubMed Hjalmarsson C, Ohlson M, Haraldsson B (2001) Puromycin aminonucleoside damages the glomerular size barrier with minimal effects on charge density. Am J Physiol Renal Physiol 281:F503–F512PubMed
43.
Zurück zum Zitat Jeansson M, Haraldsson B (2006) Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 290:F111–F116PubMedCrossRef Jeansson M, Haraldsson B (2006) Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am J Physiol Renal Physiol 290:F111–F116PubMedCrossRef
44.
Zurück zum Zitat Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652PubMedCrossRef Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652PubMedCrossRef
45.
Zurück zum Zitat Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S (1992) Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41:566–570PubMedCrossRef Border WA, Noble NA, Yamamoto T, Tomooka S, Kagami S (1992) Antagonists of transforming growth factor-beta: a novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis. Kidney Int 41:566–570PubMedCrossRef
46.
Zurück zum Zitat Border WA, Noble NA, Yamamoto T et al (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361–364PubMedCrossRef Border WA, Noble NA, Yamamoto T et al (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361–364PubMedCrossRef
47.
Zurück zum Zitat Hildebrand A, Romaris M, Rasmussen LM et al (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527–534PubMed Hildebrand A, Romaris M, Rasmussen LM et al (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302:527–534PubMed
48.
Zurück zum Zitat Mogyorosi A, Ziyadeh FN (1998) Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275:F827–F832PubMed Mogyorosi A, Ziyadeh FN (1998) Increased decorin mRNA in diabetic mouse kidney and in mesangial and tubular cells cultured in high glucose. Am J Physiol 275:F827–F832PubMed
Metadaten
Titel
Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice
verfasst von
M. Jeansson
A. Björnson Granqvist
J. Sörensson Nyström
B. Haraldsson
Publikationsdatum
01.09.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 9/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0319-z

Weitere Artikel der Ausgabe 9/2006

Diabetologia 9/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.